Prospects for an AIDS vaccine: encourage innate immunity. Read more about Prospects for an AIDS vaccine: encourage innate immunity.
Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART. Read more about Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART.
Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen. Read more about Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen.
Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy. Read more about Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy.
Early age of first sex: a risk factor for HIV infection among women in Zimbabwe. Read more about Early age of first sex: a risk factor for HIV infection among women in Zimbabwe.
Retraction. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase. Read more about Retraction. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase.
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. Read more about Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.
Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. Read more about Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.
Virological evaluation of the 'Ottawa case' indicates no evidence for HIV-1 superinfection. Read more about Virological evaluation of the 'Ottawa case' indicates no evidence for HIV-1 superinfection.
Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. Read more about Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.
